Skip to main content
. 2018 May 22;9(39):25474–25490. doi: 10.18632/oncotarget.25312

Figure 5.

Figure 5

Time to recurrence (TTR) and accumulative recurrence rate (A-E), and survival after recurrence (SAR) and survival rate (F-J), by clinicopathological factors. TTR and accumulative recurrence rate in: (A) stage I patients by colon cancer (CC) and rectal cancer (RC), (B) stage II patients by CC and RC, (C) stage III patients by CC and RC, (D) CC by stage, (E) RC by stage. SAR and survival rate in: (F) stage I patients by CC and RC, (G) stage II patients by CC and RC, (H) stage III patients by CC and RC, (I) CC by stage, (J) RC by stage. Subgroups were compared with log-rank test. P values were provided when differences were significant (P<0.05) and NS was used when differences were not significant.